Coherus Oncology (CHRS)

Coherus Oncology (CHRS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CHRS last traded at $0.83, -7.60% on the day.
• Coherus Oncology: market cap $128.25M, P/E -0.7, revenue $50.94M over the last four quarters, next earnings 2026-11-09.
• Over the past year CHRS returned -51.17%; year to date -41.54%.

Updated 2026-11-03 02:46 UTC